Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Patterns of Care and Outcomes of Adults ≥ 40 Years of Age with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL): A Multicenter Registry Analysis from India

Punit Jain, Hasmukh Jain, Rup Jyoti Sarma, Uday Kulkarni, Parathan Karunakaran, Shuvadeep Ganguly, Prasanth Ganesan, Rajeev Lk, Sharat Damodar, Rajan Kapoor, Rasmi Palassery, Unni Krishnan, Reshma Roshan, Aakash Chozakade, Aravind D, Prasanna Samuel, Om Prakash, Vikram Mathews, Manju Sengar

Blood (2024) 144 (Supplement 1): 5858.

https://doi.org/10.1182/blood-2024-207077

Published: 2024

Journal Articles

Lonah Trial: A Phase III Randomized Study of Low Dose Nivolumab Plus AVD or ABVD in Patients with Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma

Anu Korula, Hasmukh Jain, Prasanth Ganesan, Uday Kulkarni, Prasanna Samuel, Manju Sengar, Vikram Mathews

Blood (2024) 144 (Supplement 1): 3055.1.

https://doi.org/10.1182/blood-2024-204488

Published: 2024

Journal Articles

Lower Mycophenolic Acid Exposure in Patients Undergoing Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide/ Cyclosporine a-Based GvHD Prophylaxis - Need for Dose Intensification

Aswin Anand Pai, John C Panetta, Nayanthara Bijukumar, Rachel Mariam Renji, Manoj A, Agila Jayaraman, Sujith Karumathil, Anu Korula, Sushil Selvarajan, Alok Srivastava, Aby Abraham, Vikram Mathews, Biju George, Uday Kulkarni, Poonkuzhali Balasubramanian

Blood (2024) 144 (Supplement 1): 2150.

https://doi.org/10.1182/blood-2024-203105

Published: 2024

Journal Articles

Factor VIII Expression from a Novel F8 Transgene through a Lentiviral Vector Transduced CD34+ Autologous Hematopoietic Stem Cells for Gene Therapy of Severe Hemophilia Α: Final Results from a Phase 1 Clinical Trial

Blood (2024) 144 (Supplement 1): 1052.

https://doi.org/10.1182/blood-2024-202882

Published: 2024

Journal Articles

Rationalization of Anti-PD-1 Therapy Using Receptor Occupancy Data to Guide Drug Dosing - a Single Arm Phase II Trial Using Immunomodulation in Relapsed/Refractory Hodgkin Lymphoma

Anu Korula, Arun Arunachalam, Uday Kulkarni, Phaneendra Venkateswara Rao Datari, Sumith Mathew, Aswin Anand PAI, Sushil Selvarajan, Fouzia N., Aby Abraham, Biju George, Poonkuzhali Balasubramanian, Vikram Mathews

Blood (2024) 144 (Supplement 1): 647.

https://doi.org/10.1182/blood-2024-201172

Published: 2024

Journal Articles

Safety, Efficacy and Total Cost of Therapy of Decentralized, Point-of-Care Manufactured Anti-CD19 CAR-T Cells for Relapsed or Refractory B Cell Leukemia and Lymphoma: Results from the First Phase 1 Indian Trial (VELCART)

Palani Hamenth Kumar, Arun Kumar Arunachalam, Mohammed Yasar, Phaneendra Venkateswara Rao Datari, Uday Kulkarni, Sushil Selvarajan, Anu Korula, Aby Abraham, Biju George, Vikram Mathews

Blood (2024) 144 (Supplement 1): 2090.

https://doi.org/10.1182/blood-2024-201902

Published: 2024

Journal Articles

Dose Optimization of Check-Point Inhibitors: A Comparison of Standard Dose and Low Dose Nivolumab in Relapsed/Refractory Hodgkin Lymphoma

Chirag Trivedi, Sujith Kumar, Sushil Selvarajan, Sharon Anbumalar Lionel, Anup J Devasia, Fouzia N., Uday Kulkarni, Aby Abraham, Alok Srivastava, Biju George, Vikram Mathews, Anu Korula

Blood (2024) 144 (Supplement 1): 3048.

https://doi.org/10.1182/blood-2024-198979

Published: 2024

Journal Articles

Impact of Consolidation Radiotherapy in Bulky Diffuse Large B Cell Lymphoma By PET Based Response Assessment

Blood (2024) 144 (Supplement 1): 3078.

https://doi.org/10.1182/blood-2024-203645

Published: 2024

Journal Articles

EASIX d0 Predicts Early Transplant-Related Mortality in Patients Undergoing Haploidentical Transplantation with Post-Transplant Cyclophosphamide-Mycophenolate Mofetil-Based GvHD Prophylaxis

Aswin Anand Pai, Nieshanth Parthiban, Nayanthara Bijukumar, Rachel Mariam Renji, Manoj A, Sujith Karumathil, Kavitha M Lakshmi, Sushil Selvarajan, Anu Korula, Fouzia NA, Aby Abraham, Alok Srivastava, Vikram Mathews, Biju George, Uday Kulkarni, Poonkuzhali Balasubramanian

Blood (2024) 144 (Supplement 1): 4879.

https://doi.org/10.1182/blood-2024-201901

Published: 2024

Journal Articles

Outcomes and Prognostic Factors in Patients with Primary Mediastinal B Cell Lymphoma: An Experience from Hematology Cancer Consortium

Akhil Rajendra, Alok Shetty, Anu Korula, Hasmukh Jain, Mobin Paul, Prasanth Ganesan, Jayachandran Perumal Kalaiyarasi, Santhosh Kumar Devadas, Sushil Selvarajan, Abhilash Menon, Divya K, Parathan Karunakaran, Lingaraj Nayak, Om Prakash, Bhausaheb Bagal, Aby Abraham, Prasanna Samuel, Uday Kulkarni

Blood (2023) 142 (Supplement 1): 3141.

https://doi.org/10.1182/blood-2023-186670

Published: 2023

Journal Articles

Fludarabine and Melphalan Reduced Toxicity Versus a Myeloablative Fludarabine and Busulfan Conditioning Regimen for Acute Myeloid Leukemia

Vikram Mathews, Uday Kulkarni, Sushil Selvarajan, Nutan Damodar Joshi, Fouzia NA, Anu Korula, Sharon Anbumalar Lionel, Kavitha M Lakshmi, Alok Srivastava, Biju George, Aby Abraham

Blood (2023) 142 (Supplement 1): 4907.

https://doi.org/10.1182/blood-2023-188868

Published: 2023

Journal Articles

Patterns of Care and Outcome in Adolescent and Young Adults (AYA) Lymphomas- a Multicenter HCC (Hematologic Cancer Consortium) Registry Study from India

Lingaraj Nayak, Sushil Selvarajan, Hasmukh Jain, Parathan Karunakaran, Prasanth Ganesan, Jayachandran Perumal Kalaiyarasi, Nikita Mehra, Anu Korula, Uday Kulkarni, Aby Abraham, Alok Parekh, Ritam Joarder, Santhosh Kumar Devadas, Jina Bhattacharyya, Dubashi Biswajit, Vineetha Raghavan, Mobin Paul

Blood (2023) 142 (Supplement 1): 2412.

https://doi.org/10.1182/blood-2023-185774

Published: 2023

Journal Articles

Prospective Evaluation of a Defined Replacement Protocol for Peri-Operative Hemostasis in Patients with Severe Hemophilia Α with and without Inhibitors on Emicizumab Prophylaxis Undergoing Elective Major Surgeries. (EmiSurg Study)

Blood (2023) 142 (Supplement 1): 5513.

https://doi.org/10.1182/blood-2023-184564

Published: 2023

Journal Articles

Induction Related Mortality Score in Acute Myeloid Leukemia: Prospective Validation Study (pRISM) of the Hematology Cancer Consortium (HCC)

Blood (2022) 140 (Supplement 1): 3223–3224.

https://doi.org/10.1182/blood-2022-169001

Published: 2022

Journal Articles

Population Pharmacokinetics of Mycophenolic Acid in Haploidentical Transplant Recipients Receiving Post-Transplant Cyclophosphamide Based GvHD Prophylaxis

Aswin Anand PAI, Uday Kulkarni, Binu Susan Mathew, Nayanthara KB, John C Panetta, Sujith Karumathil, Aby Abraham, Vikram Mathews, Biju George, Poonkuzhali Balasubramanian

Blood (2022) 140 (Supplement 1): 10473–10474.

https://doi.org/10.1182/blood-2022-168894

Published: 2022

Journal Articles

Management of Relapsed Acute Promyelocytic Leukemia Post ATO Upfront Therapy: Open-Labeled Phase II Study Evaluating Role of Proteasome Inhibition

Vikram Mathews, MD DM, Anu Korula, MD DM, Uday Kulkarni, MD, Saravanan Ganesan, MSc, Sachin David, MSc, Ansu Abu Alex, MSc, Nisham PN, MD DM, Aby Abraham, MD DM, Alok Srivastava, Kavitha M Lakshmi, MSc, Poonkuzhali Balasubramanian, MSc PhD, Biju George, MD DM

Blood (2016) 128 (22): 446.

https://doi.org/10.1182/blood.V128.22.446.446

Published: 2016

Journal Articles

Coagulopathy in Acute Promyelocytic Leukemia: Strategies to Improve Assessment of Hemostatic Risk

Sachin David, MSc, Vandana Kamath, MD, Uday Kulkarni, MD, Ramya Vijayan, Msc, Anu Korula, MD DM, Fouzia NA, Dip NB, DM,, Nisham PN, DM, Alok Srivastava, MD, Kavitha M Lakshmi, MSc, Poonkuzhali Balasubramanian, M.Sc., PhD, Biju George, DM, Sukesh Nair, M.B.B.S, DCP, DNB, FRCPA, Vikram Mathews, DM

Blood (2015) 126 (23): 3758.

https://doi.org/10.1182/blood.V126.23.3758.3758

Published: 2015

NARROW

Patterns of Care and Outcomes of Adults ≥ 40 Years of Age with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL): A Multicenter Registry Analysis from India

Lonah Trial: A Phase III Randomized Study of Low Dose Nivolumab Plus AVD or ABVD in Patients with Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma

Lower Mycophenolic Acid Exposure in Patients Undergoing Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide/ Cyclosporine a-Based GvHD Prophylaxis - Need for Dose Intensification

Factor VIII Expression from a Novel F8 Transgene through a Lentiviral Vector Transduced CD34+ Autologous Hematopoietic Stem Cells for Gene Therapy of Severe Hemophilia Α: Final Results from a Phase 1 Clinical Trial

Rationalization of Anti-PD-1 Therapy Using Receptor Occupancy Data to Guide Drug Dosing - a Single Arm Phase II Trial Using Immunomodulation in Relapsed/Refractory Hodgkin Lymphoma

Safety, Efficacy and Total Cost of Therapy of Decentralized, Point-of-Care Manufactured Anti-CD19 CAR-T Cells for Relapsed or Refractory B Cell Leukemia and Lymphoma: Results from the First Phase 1 Indian Trial (VELCART)

Dose Optimization of Check-Point Inhibitors: A Comparison of Standard Dose and Low Dose Nivolumab in Relapsed/Refractory Hodgkin Lymphoma

Impact of Consolidation Radiotherapy in Bulky Diffuse Large B Cell Lymphoma By PET Based Response Assessment

EASIX d0 Predicts Early Transplant-Related Mortality in Patients Undergoing Haploidentical Transplantation with Post-Transplant Cyclophosphamide-Mycophenolate Mofetil-Based GvHD Prophylaxis

Outcomes and Prognostic Factors in Patients with Primary Mediastinal B Cell Lymphoma: An Experience from Hematology Cancer Consortium

Fludarabine and Melphalan Reduced Toxicity Versus a Myeloablative Fludarabine and Busulfan Conditioning Regimen for Acute Myeloid Leukemia

Patterns of Care and Outcome in Adolescent and Young Adults (AYA) Lymphomas- a Multicenter HCC (Hematologic Cancer Consortium) Registry Study from India

Prospective Evaluation of a Defined Replacement Protocol for Peri-Operative Hemostasis in Patients with Severe Hemophilia Α with and without Inhibitors on Emicizumab Prophylaxis Undergoing Elective Major Surgeries. (EmiSurg Study)

Induction Related Mortality Score in Acute Myeloid Leukemia: Prospective Validation Study (pRISM) of the Hematology Cancer Consortium (HCC)

Population Pharmacokinetics of Mycophenolic Acid in Haploidentical Transplant Recipients Receiving Post-Transplant Cyclophosphamide Based GvHD Prophylaxis

Management of Relapsed Acute Promyelocytic Leukemia Post ATO Upfront Therapy: Open-Labeled Phase II Study Evaluating Role of Proteasome Inhibition

Coagulopathy in Acute Promyelocytic Leukemia: Strategies to Improve Assessment of Hemostatic Risk

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only